• / Free eNewsletters & Magazine
  • / My Account
Home>‘Trying to Recapture the Magic’: The Strategy Behind the Pharma M&A Rush

‘Trying to Recapture the Magic’: The Strategy Behind the Pharma M&A Rush

Perspectives Content Submission

Fri, 30 May 2014

Published with permission from  Knowledge @ Wharton , Wharton’s online business journal. More than $200 billion is at play in the current round of M&A activity in the pharmaceutical industry – a frenzy that includes 14 deals announced so far this year. This compares with 10 deals last year, accordi

Related Videos

  1. 3 M&A Takeaways

    Merger activity sizzles in the food business, Apple experiments with Beats, and Pfizer stays disciplined.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.